Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000639722 | SCV000761303 | uncertain significance | Neuronopathy, distal hereditary motor, type 7A; Congenital myasthenic syndrome 20 | 2025-02-02 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 548 of the SLC5A7 protein (p.Arg548Gln). This variant is present in population databases (rs199864231, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with SLC5A7-related conditions. ClinVar contains an entry for this variant (Variation ID: 532814). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000639722 | SCV000896798 | uncertain significance | Neuronopathy, distal hereditary motor, type 7A; Congenital myasthenic syndrome 20 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404792 | SCV002709243 | likely benign | Inborn genetic diseases | 2019-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437351 | SCV004148956 | uncertain significance | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003437351 | SCV005412860 | uncertain significance | not provided | 2023-10-05 | criteria provided, single submitter | clinical testing |